| Topological organization of the hyaluronan synthase fromstreptococcus pyogenes C Heldermon, PL DeAngelis, PH Weigel Journal of Biological Chemistry 276 (3), 2037-2046, 2001 | 125 | 2001 |
| Kinetic characterization of the recombinant hyaluronan synthases from Streptococcus pyogenes and Streptococcus equisimilis VL Tlapak-Simmons, BA Baggenstoss, K Kumari, C Heldermon, ... Journal of Biological Chemistry 274 (7), 4246-4253, 1999 | 102 | 1999 |
| Development of sensory, motor and behavioral deficits in the murine model of Sanfilippo syndrome type B CD Heldermon, AK Hennig, KK Ohlemiller, JM Ogilvie, ED Herzog, ... PloS one 2 (8), e772, 2007 | 100 | 2007 |
| TRIM29 suppresses TWIST1 and invasive breast cancer behavior L Ai, WJ Kim, M Alpay, M Tang, CE Pardo, S Hatakeyama, WS May, ... Cancer research 74 (17), 4875-4887, 2014 | 98 | 2014 |
| Therapeutic efficacy of bone marrow transplant, intracranial AAV-mediated gene therapy, or both in the mouse model of MPS IIIB CD Heldermon, KK Ohlemiller, ED Herzog, C Vogler, E Qin, DF Wozniak, ... Molecular Therapy 18 (5), 873-880, 2010 | 83 | 2010 |
| Epithelial-to-mesenchymal transition confers pericyte properties on cancer cells AK Shenoy, Y Jin, H Luo, M Tang, C Pampo, R Shao, DW Siemann, L Wu, ... The Journal of clinical investigation 126 (11), 4174-4186, 2016 | 82 | 2016 |
| Differential expression and function of CAIX and CAXII in breast cancer: A comparison between tumorgraft models and cells Z Chen, L Ai, MY Mboge, C Tu, R McKenna, KD Brown, CD Heldermon, ... PLoS one 13 (7), e0199476, 2018 | 73 | 2018 |
| High resolution functional photoacoustic tomography of breast cancer X Li, CD Heldermon, L Yao, L Xi, H Jiang Medical physics 42 (9), 5321-5328, 2015 | 71 | 2015 |
| Mucopolysaccharidosis III (Sanfilippo Syndrome)-disease presentation and experimental therapies. JA Gilkes, CD Heldermon Pediatric endocrinology reviews: PER 12, 133-140, 2014 | 57 | 2014 |
| Preferred transduction with AAV8 and AAV9 via thalamic administration in the MPS IIIB model: A comparison of four rAAV serotypes JA Gilkes, MD Bloom, CD Heldermon Molecular genetics and metabolism reports 6, 48-54, 2016 | 55 | 2016 |
| Disease correction by combined neonatal intracranial AAV and systemic lentiviral gene therapy in Sanfilippo Syndrome type B mice CD Heldermon, EY Qin, KK Ohlemiller, ED Herzog, JR Brown, C Vogler, ... Gene therapy 20 (9), 913-921, 2013 | 48 | 2013 |
| Novel agents that downregulate EGFR, HER2, and HER3 in parallel RB Ferreira, ME Law, SC Jahn, BJ Davis, CD Heldermon, M Reinhard, ... Oncotarget 6 (12), 10445, 2015 | 35 | 2015 |
| A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells MY Mboge, Z Chen, D Khokhar, A Wolff, L Ai, CD Heldermon, M Bozdag, ... Biochemical Journal 476 (10), 1497-1513, 2019 | 33 | 2019 |
| Site-directed mutation of conserved cysteine residues does not inactivate the Streptococcus pyogenes hyaluronan synthase CD Heldermon, VL Tlapak-Simmons, BA Baggenstoss, PH Weigel Glycobiology 11 (12), 1017-1024, 2001 | 30 | 2001 |
| EMPOWERS: A phase 1/2 clinical trial of SB-318 ZFN-mediated in vivo human genome editing for treatment of MPS I (Hurler syndrome) P Harmatz, HA Lau, C Heldermon, N Leslie, CWP Foo, SA Vaidya, ... Mol. Genet. Metab 126, S68, 2019 | 29 | 2019 |
| Epidemiological, clinical, and histopathological features of breast cancer in Haiti V DeGennaro Jr, F Jiwani, E Patberg, M Gibbs, R Libby, D Gabriel, ... Journal of Global Oncology 4, 1-9, 2018 | 29 | 2018 |
| Mucopolysaccharidosis IIIB confers enhanced neonatal intracranial transduction by AAV8 but not by 5, 9 or rh10 JA Gilkes, MD Bloom, CD Heldermon Gene therapy 23 (3), 263-271, 2016 | 29 | 2016 |
| Expression and DNA binding of the human 52 kDa Ro/SSA autoantigen MB Frank, VR McCUBBIN, C Heldermon Biochemical Journal 305 (2), 359-362, 1995 | 28 | 1995 |
| Disulfide bond disrupting agents activate the unfolded protein response in EGFR-and HER2-positive breast tumor cells RB Ferreira, M Wang, ME Law, BJ Davis, AN Bartley, PJ Higgins, ... Oncotarget 8 (17), 28971, 2017 | 20 | 2017 |
| Five-year breast surgeon experience in LYMPHA at time of ALND for treatment of clinical T1–4N1–3M0 breast cancer KM Herremans, MP Cribbin, AN Riner, DW Neal, TL Hollen, P Clevenger, ... Annals of surgical oncology 28 (10), 5775-5787, 2021 | 15 | 2021 |
